Wockhardt Establishes Three New Step-Down Subsidiaries in Switzerland and the USA

1 min read     Updated on 16 Dec 2025, 06:56 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Wockhardt has announced the creation of three new step-down subsidiaries in Switzerland and the United States. This strategic move aims to expand the company's international operations and strengthen its presence in key global pharmaceutical markets. The new entities are expected to enhance Wockhardt's market access, operational efficiency, and strategic positioning in these regions.

27437209

*this image is generated using AI for illustrative purposes only.

Wockhardt has announced the establishment of three new step-down subsidiaries, marking a significant expansion of its international operations. The pharmaceutical company has strategically positioned these new entities across Switzerland and the United States, two key markets in the global pharmaceutical landscape.

Strategic International Expansion

The creation of these step-down subsidiaries represents a calculated move by Wockhardt to strengthen its global operational framework. By establishing entities in Switzerland and the USA, the company is positioning itself to better serve these critical markets while potentially benefiting from local regulatory and operational advantages.

Subsidiary Structure Details

Parameter Details
Total Subsidiaries Three new entities
Geographic Locations Switzerland and USA
Subsidiary Type Step-down subsidiaries
Strategic Focus International market expansion

Market Positioning

The establishment of these subsidiaries in Switzerland and the United States demonstrates Wockhardt's commitment to expanding its international footprint. Switzerland, known for its robust pharmaceutical sector and favorable business environment, along with the United States, one of the world's largest pharmaceutical markets, provide strategic advantages for the company's global operations.

Corporate Structure Enhancement

These new step-down subsidiaries will likely serve as important components of Wockhardt's international corporate structure, potentially facilitating better market access, operational efficiency, and strategic positioning in these key regions. The move reflects the company's ongoing efforts to optimize its global presence and operational capabilities in pharmaceutical markets.

This strategic expansion aims to strengthen Wockhardt's global presence and potentially enhance its competitiveness in international pharmaceutical markets. The establishment of these subsidiaries underscores the company's commitment to growth and its focus on expanding its operational reach beyond domestic borders.

Historical Stock Returns for Wockhardt

1 Day5 Days1 Month6 Months1 Year5 Years
-0.55%+5.75%+11.17%-16.98%-3.57%+217.87%
Wockhardt
View in Depthredirect
like17
dislike

Wockhardt Shareholders Approve Om Prakash Bhatt's Appointment as Independent Director

2 min read     Updated on 15 Dec 2025, 06:10 PM
scanx
Reviewed by
Riya DScanX News Team
Overview

Wockhardt Limited shareholders have overwhelmingly approved the appointment of Om Prakash Bhatt as Non-Executive Independent Director for a five-year term through postal ballot with 99.99% approval. The voting process involved 770 shareholders out of 144,639 total shareholders, with the scrutinizer's report officially confirming the results and validating the transparent e-voting procedure conducted through NSDL platform.

27348024

*this image is generated using AI for illustrative purposes only.

Wockhardt Limited shareholders have overwhelmingly approved the appointment of Om Prakash Bhatt as Non-Executive Independent Director for a five-year term through a postal ballot. The company announced that 99.99% of votes were cast in favor of the appointment, with the scrutinizer's report officially confirming the results.

Appointment Details and Term

The special resolution approved Mr. Om Prakash Bhatt's appointment with Director Identification Number (DIN) 00548091 for a comprehensive five-year term. The appointment specifics are outlined below:

Parameter: Details
Director Name: Om Prakash Bhatt
DIN: 00548091
Position: Non-Executive Independent Director
Term Duration: 5 years
Term Period: November 3, 2025 to November 2, 2030
Age Provision: Continuation despite reaching 75 years during term

Voting Results and Participation

The postal ballot demonstrated strong shareholder support across all categories. The e-voting process recorded exceptional participation and approval rates with 770 shareholders participating out of 144,639 total shareholders on record.

Overall Voting Statistics

Metric: Count
Total Shareholders on Record: 144,639
Participating Shareholders: 770
Total Valid Votes: 108,193,119
Invalid Votes: 2,031
Votes in Favor: 108,184,521
Votes Against: 8,598
Approval Percentage: 99.99%

Category-wise Voting Breakdown

The voting results showed unanimous support across different shareholder categories:

Category: Shares Held Votes Polled Votes in Favor (%) Votes Against (%)
Promoter & Promoter Group: 79,758,848 79,758,848 100.00% 0.00%
Public Institutions: 24,675,846 24,675,846 100.00% 0.00%
Public Non-Institutions: 37,584,256 37,498,278 99.77% 0.23%

Voting Process and Compliance

The postal ballot was conducted in accordance with Section 110 of the Companies Act, 2013, and the Companies (Management and Administration) Rules, 2014. The remote e-voting facility was provided through National Securities Depository Limited (NSDL) platform, ensuring secure and transparent participation.

Key process highlights included:

  • Record Date: November 7, 2025
  • E-voting Period: November 15, 2025 to December 14, 2025
  • Notice Distribution: Electronic mode only to registered email addresses
  • Newspaper Publication: Business Standard (English) and Lokmat (Marathi) on November 15, 2025

Scrutinizer Report and Validation

Mr. Virendra G. Bhatt, Practicing Company Secretary (ACS No. 1157), served as the appointed scrutinizer for the postal ballot process. His report confirmed the validity and fairness of the voting procedure, with all electronic data and relevant records maintained under safe custody. The scrutinizer's report was issued on December 15, 2025, validating the overwhelming shareholder approval for the resolution.

The e-voting process concluded at 5:00 p.m. on December 14, 2025, and the votes were unblocked in the presence of two independent witnesses, Ms. Khushi Gangwal and Mr. Sahil Pawar, who are not in the employment of the company or NSDL. The appointment strengthens Wockhardt's board composition with an experienced independent director, reflecting strong shareholder confidence in the company's governance structure and strategic direction.

Historical Stock Returns for Wockhardt

1 Day5 Days1 Month6 Months1 Year5 Years
-0.55%+5.75%+11.17%-16.98%-3.57%+217.87%
Wockhardt
View in Depthredirect
like15
dislike
More News on Wockhardt
Explore Other Articles
1,437.00
-7.90
(-0.55%)